GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (NAS:RMTI) » Definitions » Cyclically Adjusted PS Ratio

RMTI (Rockwell Medical) Cyclically Adjusted PS Ratio : 0.09 (As of May. 28, 2025)


View and export this data going back to 1998. Start your Free Trial

What is Rockwell Medical Cyclically Adjusted PS Ratio?

As of today (2025-05-28), Rockwell Medical's current share price is $0.9598. Rockwell Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $10.81. Rockwell Medical's Cyclically Adjusted PS Ratio for today is 0.09.

The historical rank and industry rank for Rockwell Medical's Cyclically Adjusted PS Ratio or its related term are showing as below:

RMTI' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.06   Med: 1.1   Max: 5.9
Current: 0.09

During the past years, Rockwell Medical's highest Cyclically Adjusted PS Ratio was 5.90. The lowest was 0.06. And the median was 1.10.

RMTI's Cyclically Adjusted PS Ratio is ranked better than
97.29% of 737 companies
in the Drug Manufacturers industry
Industry Median: 2.1 vs RMTI: 0.09

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Rockwell Medical's adjusted revenue per share data for the three months ended in Mar. 2025 was $0.555. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $10.81 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Rockwell Medical Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Rockwell Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rockwell Medical Cyclically Adjusted PS Ratio Chart

Rockwell Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.29 0.07 0.15 0.19

Rockwell Medical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.15 0.35 0.19 0.10

Competitive Comparison of Rockwell Medical's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Cyclically Adjusted PS Ratio falls into.


;
;

Rockwell Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Rockwell Medical's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.9598/10.81
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Rockwell Medical's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.555/134.9266*134.9266
=0.555

Current CPI (Mar. 2025) = 134.9266.

Rockwell Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2.846 100.684 3.814
201509 3.149 100.392 4.232
201512 3.177 99.792 4.296
201603 2.958 100.470 3.972
201606 2.920 101.688 3.874
201609 2.782 101.861 3.685
201612 2.883 101.863 3.819
201703 3.167 102.862 4.154
201706 2.855 103.349 3.727
201709 3.139 104.136 4.067
201712 3.183 104.011 4.129
201803 3.206 105.290 4.108
201806 3.198 106.317 4.059
201809 3.575 106.507 4.529
201812 3.228 105.998 4.109
201903 2.997 107.251 3.770
201906 2.805 108.070 3.502
201909 2.656 108.329 3.308
201912 2.642 108.420 3.288
202003 2.583 108.902 3.200
202006 2.518 108.767 3.124
202009 2.341 109.815 2.876
202012 1.780 109.897 2.185
202103 1.818 111.754 2.195
202106 1.777 114.631 2.092
202109 1.873 115.734 2.184
202112 1.795 117.630 2.059
202203 1.887 121.301 2.099
202206 1.612 125.017 1.740
202209 1.012 125.227 1.090
202212 1.043 125.222 1.124
202303 1.071 127.348 1.135
202306 0.977 128.729 1.024
202309 0.864 129.860 0.898
202312 0.769 129.419 0.802
202403 0.773 131.776 0.791
202406 0.806 132.554 0.820
202409 0.873 133.029 0.885
202412 0.750 133.157 0.760
202503 0.555 134.927 0.555

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Rockwell Medical  (NAS:RMTI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Rockwell Medical Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rockwell Medical Business Description

Traded in Other Exchanges
Address
30142 S. Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
Executives
Jesse Neri officer: SVP, FINANCE 851 DUPORTAIL ROAD, SECOND FLOOR, CHESTERBROOK PA 19087
Mark Strobeck director, officer: President and CEO 460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087
Mark H Ravich other: See Footnote 1
Joan Lau director C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Russell Skibsted officer: See Remarks 15 TRANQUILITY PLACE, LADERA RANCH CA 92694
Megan C. Timmins officer: SVP, General Counsel 600 LEE ROAD, SUITE 100, WAYNE PA 19087
Allen Nissenson director 601 HAWAII ST., EL SEGUNDO CA 90245
Robert S Radie director 101 LINDENWOOD DRIVE, SUITE 225, MALVERN PA 19355
Andrea Heslin Smiley director 600 LEE ROAD, SUITE 100, WAYNE PA 19087
David S. Richmond 10 percent owner, other: See Footnote 1 3568 WILDWOOD AVENUE, JACKSON MI 49202
Russell H Ellison director 270 RIVERSIDE DR., APT. 12D, NEW YORK NY 10025
Marc L Hoffman officer: Chief Medical Officer 30142 WIXOM ROAD, WIXOM MI 48393
John Peter Mclaughlin director C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451
Richmond Brothers, Inc. 10 percent owner, other: See Footnote 1 7415 FOXWORTH COURT, JACKSON MI 49201
Stuart M Paul director, officer: Chief Executive Officer HOME DIAGNOSTICS, INC., 2400 NW 55TH COURT, FORT LAUDERDALE FL 33309